By Julian Castillo
Biotechnology company Loyal has announced an exciting breakthrough in the search for medications that can extend the life of our faithful canine friends. According to a recent statement, the US Food and Drug Administration has recognized the potential effectiveness of a drug developed by Loyal, marking an important milestone for the approval of a breakthrough treatment.
The drug, not yet identified for intellectual property reasons, has passed one of the requirements for “expanded conditional approval.”, an expedited authorization for animal medicines that address unmet health needs. Although not yet available to pet owners, Loyal aims to receive conditional approval in 2026. This would allow the medicine for prolong the life of dogs reach the market before the completion of a large clinical trial.
1 more year of life
Celine Halioua, Founder and CEO of Loyal, shares her excitement by stating that They hope to “extend at least one year of healthy life extension”. However, uncertainty remains, as the drug has yet to be conclusively proven to deliver on this ambitious promise.
Although one small study suggests that LOY-001 drug could mitigate metabolic changes associated with aging, Loyal has yet to demonstrate its ability to prolong the lives of dogs. The FDA letter, the result of years of dialogue between the company and the regulatory agency, indicates an openness on the part of the FDA toward drugs aimed at canine longevity.
Other medications
The field of canine longevity is booming. Other researchers are conducting clinical trials with rapamycin, a substance that has been shown to extend the life of laboratory mice. In parallel, Loyal is recruiting dogs for clinical trials of another drug candidate, called LOY-002.
The drugs being studied act in various ways. Rapamycin, which is also being investigated as a possible drug for human longevity, inhibits the protein mTOR, which regulates cell growth and metabolism. Preliminary results from a study involving dogs given rapamycin suggest improvements in health and behaviorwhich fuels hope that these advances will not only prolong life, but also improve the quality of it.
The field of biotechnology is on the threshold of a significant milestone that could change the way we care for and understand the lives of our beloved canine companions. With conditional approval on the horizon, the possibility of longer, healthier lives for dogs is closer to becoming a reality.
Keep reading:
– Mysterious respiratory disease spreads rapidly among dogs in the US.
– Study tests intelligence of dogs, concludes that the Labrador is the most clumsy
– The least suitable dog breeds for children